[1]
M. J. Sotelo Lezama, C. Aguado de la Rosa, B. García-Paredes, J. Sastre Valera, S. C. Camarero, and E. Díaz-Rubio, “FOLFIRI regimen as second-line treatment of metastatic gastric cancer: a retrospective analysis of efficacy, safety and prognostic factors”, Eur J Oncol Env Hea, vol. 20, no. 1, pp. 32–40, Sep. 2015, Accessed: Feb. 23, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4168